Glyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude
TechCrunch
JULY 26, 2021
Glyphic Biotechnologies accelerates the critical but slow sequencing step, potentially cutting drug development times down by a huge amount, and the startup just raised a $6 million seed to bring its clever solution to market. As a result there’s a certain amount of uncertainty and a lack of unreliability inherent to the process.
Let's personalize your content